* Penumbra Inc PEN.N reported quarterly adjusted earnings
of 97
cents per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of 76
cents. The mean expectation of eighteen analysts for the
quarter was for earnings of 90 cents per share. Wall Street
expected results to range from 80 cents to $1.08 per share.
* Revenue rose 10.8% to $315.52 million from a year ago;
analysts
expected $311.52 million.
* Penumbra Inc's reported EPS for the quarter was 86 cents.
* The company reported quarterly net income of $33.68
million.
* Penumbra Inc shares had risen by 13.1% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Penumbra Inc is
$262.00
This summary was machine generated from LSEG data February 18 at
10:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 0.90 0.97 Beat
Sep. 30 2024 0.69 0.85 Beat
Jun. 30 2024 0.56 0.64 Beat
Mar. 31 2024 0.38 0.41 Beat